Company intelligence
Cacti
Psychedelic Therapies for Pain and Headache
Dallas, US
26 employees
3 public signals
About Cacti
Cacti is a biotech company advancing FDA approved, first-in-class "Nociplastigens" to treat chronic pain, inflammation, and opioid use disorder. Our interdisciplinary team aims to understand the psychological drivers of pain and bring transformative therapies to the patients at the heart of our mission.
Verified activity
Signals from Cacti
3 published signals
Presence & Recognition
Cacti Therapeutics announced that it will be hosting a lab day event at the Cacti Lab on September 15, 2026.
Reported by Kaitlin Roberson
Research & Knowledge
Cacti Therapeutics investigated psychedelic pharmacophores for pain using a team of pain neurobiologists four years ago.
Reported by Kaitlin Roberson
Capital & Finance
Cacti Therapeutics closed another funding round this week.
Reported by Kaitlin Roberson